The Da Nang Hospital announced on March 31 that its department of neurology – musculoskeletal – clinical hematology has ...

Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global biopharmaceutical company, and Shilpa Medicare Limited ("Shilpa") today announced the U.S. launch of BORUZU™, a new ...

The addition of subcutaneous daratumumab to triplet therapy improved outcomes for certain patients with newly diagnosed ...

Panelists discuss how patient involvement in multiple myeloma treatment decisions has evolved from a physician-directed ...

DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for cutting-edge treatment. The CAR T-cell therapy involves the col ...

That is the view of members of the West Lancs and Merseyside Myeloma Support Group, which has been helping patients and their ...